Freshpet reported significantly better-than-expected Q2 results, beating both earnings and revenue estimates, driven by strong volume growth and improved margins. The company also raised its full-year 2026 sales and adjusted EBITDA guidance, leading to a sharp stock price increase and a short squeeze due to high short interest.
Freshpet's Q2 performance was a significant positive surprise, with earnings and revenue exceeding analyst expectations. This strong operational execution, coupled with an upward revision of their fiscal 2026 sales and adjusted EBITDA guidance, signals robust underlying business health and future growth prospects. The high short interest (21% of float) amplified the stock's positive reaction, triggering a short squeeze as short sellers covered their positions. This event is a major catalyst for FRPT, likely leading to continued positive momentum in the short term, while the improved outlook supports long-term investor confidence. Traders should note the potential for further upside due to continued short covering and renewed institutional interest.